Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer is a research paper published in Carcinogenesis (2020). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Lung Association
Grant: LCD-503769
National Cancer Institute
Grant: R01CA225977
UT Lung Specialized Programs of Research Excellence
Grant: P50CA70907
M. D. Anderson Institutional Tissue Bank
Grant: 2P30CA016672
NCI NIH HHS
Grant: P50 CA070907
NCI NIH HHS
Grant: P30 CA016672
National Institutes of Health
Grant: 3P50CA070907-02S1
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCER
National Institutes of Health
Grant: 5R01CA225977-03
Immunotherapeutic Modalities for K-ras Mutant Lung Cancer: Sex- and Cell Type-Specific Roles of IL-6/STAT3 signaling
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
China Scholarship Council
NIH
FWCI
0.61
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals